newsfilter
← Latest News
GlobeNewswire·

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease